How many institutions own UBX stock?

A company's 13F filings with the Securities and Exchange Commission (SEC) provides investors with comprehensive information about institutional ownership in a listed company, a sign of strength in terms of how many institutions have confidence in that company. The number of institutional investors who currently own UBX shares is 43, representing 17.19% of the company's common stock.

Who are the major shareholders selling Unity Biotechnology, Inc. stock?

CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD., in the last quarter, reduced its stake in UBX by -100% restricting it's holding to 0 shares of worth nearly -. WELLS FARGO & COMPANY/MN also lessened -100% of the UBX shares from its portfolio, reducing its holding to 0 shares of worth -. FMR LLC also shunned UBX shares holding by -100% last quarter which brought its holding to 0 shares worth -.

Investors who are buying UBX stock?

As per its latest 13F filing, MAYO CLINIC increased its stake in UBX by 100% in the last quarter. The institutional holder raised its holding to 157.2 thousand shares having worth more than $430.72K. N/A also added N/A more shares of UBX to its portfolio, raising its holding to - shares of worth -. N/A also increased its UBX shares holding by N/A which brought its holding to - shares worth -.

UBX's major insiders: who are they?

The insider with the most stakes in UBX is David Nathaniel E , President at the company. Additionally, UBX stock is highly held by Chief Executive Officer Ghosh Anirvan and CFO & Head of Corp. Dev. Sullivan Lynne Marie among others.

Did an insider recently sell UBX stock?

Company executives, directors, and other insiders own 1.9% percent of Unity Biotechnology, Inc.'s stock. Within the last six months, there have been 0 transaction(s) in which UBX insiders have sold stock, totaling 0 shares. Insiders that have sold shares include NGUYEN ALEXANDER HIEU, GHOSH ANIRVAN, and SULLIVAN LYNNE MARIE.

Which insider recently purchased UBX stock?

There have been 0 transaction(s) during the past 6-months in which Unity Biotechnology, Inc. insiders have bought stock, totalling 0 shares

How much of UBX does insiders own?

Around 0 Unity Biotechnology, Inc. shares are held by insiders, which represents about 1.9% of UBX stock.

Who is the insider with the largest stake?

UBX President, David Nathaniel E holds the largest portfolio of the company's shares. UBX shares owned by David total nearly 624.7 thousand.

Which institution holds the most shares in UBX?

CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. is the largest institutional owner in UBX which holds 0 shares worth - or 0% of the total UBX shares outstanding followed by WELLS FARGO & COMPANY/MN with ownership of 0 shares representing 0% of the UBX ownership. FMR LLC is the third largest stakeholder with 0 shares or 0% of the ownership worth more than -.

Is Unity Biotechnology, Inc. stock optionable?

Stock options give the owner the ability but not the obligation to buy or sell a security at a predetermined price and date. Stock options can be classified into two types: puts and calls. A put is a bet on falling stock, and a call is a bet on rising stock. As far as the UBX is concerned, it is a stock which is optionable.

Is there a short position on UBX's shares?

Number of UBX shares short is 873.20K. Shares short is a market sentiment in which investors have sold their shares short in a given stock but have not yet covered them or closed them out.

About how many outstanding UBX shares are there?

As of today, 17.21M shares of UBX are outstanding.

Is there many float in UBX stock?

Float represents the number of tradeable shares in a specific stock. By subtracting restricted and closely-held shares from a firm's total outstanding shares, we can calculate its floating stock. The term "closely-held shares" refers to shares held by employees, major shareholders, and company insiders. At present, UBX has 15.88M shares in float.

UBX short ratio: what is it?

Short ratio is calculated by dividing the number of short shares, short interest or bets that shareholders will sell short from the average daily volume. A higher ratio indicates longer times needed to repurchase borrowed shares (sold). The short ratio for UBX is 4.67.

Unity Biotechnology (UBX) insider trading activity: Get Latest News Today

Stock Outstanding Shares

Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.

ShortableNo

OptionableYes

Short Percent Of Outstanding Shares5.07

Short Percent Of Float5.17

Shares Outstanding17.21M

Shares Float15.88M

Shares Short873.20K

Short Ratio4.67

5.17%

Short % of Float

5.07%

Short % of Shares Outstanding

Market Insider

Investors cannot turn a blind eye to insiders as well as institutional ownership. They need to follow insider trades to determine the direction the stock is likely to take.

Major Holders Summary

1.9% Percentage of Shares held by All Insiders

17.19% Percentage of Shares held by All Institutions

17.52% Percentage of Float held by Institutions

Number of Institutions Holding Shares

Institutional Ownership

About 17.19% of UBX shares are held by financial institutions. CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. is the top corporate investor, holding 0 shares valued at -. A 0% stake in Unity Biotechnology, Inc. is owned by the company. WELLS FARGO & COMPANY/MN owns 0 shares valued at -, which translates its holding of 0% of the stake in the company.

Date	Holder	% Stake	Shares Held	Total Value ($)	Shares	% Change in Portfolio
Dec 31, 2022	CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD.	0%	0	-	-162.04K	-100.00%
Dec 31, 2022	WELLS FARGO & COMPANY/MN	0%	0	-	-1.03K	-100.00%
Dec 31, 2022	FMR LLC	0%	0	-	-7.54M	-100.00%
Dec 31, 2022	PNC FINANCIAL SERVICES GROUP, INC.	0%	0	-	-1.5K	-100.00%
Dec 31, 2022	BAILARD, INC.	0%	0	-	-51K	-100.00%
Dec 31, 2022	VICTORY CAPITAL MANAGEMENT INC	0%	0	-	-14.01K	-100.00%
Dec 31, 2022	GOLDMAN SACHS GROUP INC	0%	0	-	-10.66K	-100.00%
Dec 31, 2022	MORGAN STANLEY	0%	0	-	-182.08K	-100.00%
Dec 31, 2022	GEODE CAPITAL MANAGEMENT, LLC	0%	0	-	-420.97K	-100.00%
Dec 31, 2022	MILLENNIUM MANAGEMENT LLC	0%	0	-	-994.79K	-100.00%
Dec 31, 2022	EQIS CAPITAL MANAGEMENT, INC.	0%	0	-	-16.92K	-100.00%
Dec 31, 2022	CANTOR FITZGERALD, L. P.	0%	0	-	-144.5K	-100.00%
Dec 31, 2022	PRUDENTIAL FINANCIAL INC	0%	0	-	-55.6K	-100.00%
Dec 31, 2022	ADAGE CAPITAL PARTNERS GP, L.L.C.	0%	0	-	-3.5M	-100.00%
Dec 31, 2022	683 CAPITAL MANAGEMENT, LLC	0%	0	-	-2.82M	-100.00%
Dec 31, 2022	CITADEL ADVISORS LLC	0%	0	-	-65.5K	-100.00%
Dec 31, 2022	FEDERATED HERMES, INC.	0%	0	-	-2.74K	-100.00%
Dec 31, 2022	BANK OF NEW YORK MELLON CORP	0%	0	-	-22.62K	-100.00%
Dec 31, 2022	MAYO CLINIC	1.66%	157.2K	430.72K	157.2K	+100.00%
Dec 31, 2022	ACADIAN ASSET MANAGEMENT LLC	0%	0	-	-487.96K	-100.00%
Dec 31, 2022	BNP PARIBAS ARBITRAGE, SNC	0%	0	-	-74	-100.00%
Dec 31, 2022	ROSENBERG MATTHEW HAMILTON	0%	200	548	-1.8K	-90.00%
Dec 31, 2022	JPMORGAN CHASE & CO	0%	0	-	-66	-100.00%
Dec 31, 2022	US BANCORP \DE\	0%	0	-	-2K	-100.00%
Dec 31, 2022	FRANKLIN RESOURCES INC	0%	0	-	-105.68K	-100.00%
Dec 31, 2022	BANK OF AMERICA CORP /DE/	0%	0	-	-76	-100.00%
Dec 31, 2022	NORTHERN TRUST CORP	0%	0	-	-66.2K	-100.00%
Dec 31, 2022	CLEARSTEAD ADVISORS, LLC	0%	0	-	-450	-100.00%
Dec 31, 2022	CHARLES SCHWAB INVESTMENT MANAGEMENT INC	0%	0	-	-45.95K	-100.00%
Dec 31, 2022	RENAISSANCE TECHNOLOGIES LLC	0%	0	-	-1.58M	-100.00%
Dec 31, 2022	SUSQUEHANNA INTERNATIONAL GROUP, LLP	0%	0	-	-390.8K	-100.00%
Dec 31, 2022	ALYESKA INVESTMENT GROUP, L.P.	0%	0	-	-1.29M	-100.00%
Dec 31, 2022	SIGNATUREFD, LLC	0%	0	-	-2K	-100.00%
Dec 31, 2022	HAP TRADING, LLC	0%	0	-	-14.7K	-100.00%
Dec 31, 2022	SIMPLEX TRADING, LLC	0%	0	-	-29.97K	-100.00%
Dec 31, 2022	TOWER RESEARCH CAPITAL LLC (TRC)	0%	0	-	-41	-100.00%
Dec 31, 2022	VIRTU FINANCIAL LLC	0%	0	-	-35.1K	-100.00%
Dec 31, 2022	WESTSIDE INVESTMENT MANAGEMENT, INC.	0%	0	-	-100	-100.00%
Dec 31, 2022	CREATIVE PLANNING	0%	0	-	-30.79K	-100.00%
Dec 31, 2022	BUCKINGHAM STRATEGIC WEALTH, LLC	0%	0	-	-17.72K	-100.00%
Dec 31, 2022	STATE STREET CORP	0%	0	-	-172.64K	-100.00%
Dec 31, 2022	VANGUARD GROUP INC	0%	0	-	-4.44M	-100.00%
Dec 31, 2022	GROUP ONE TRADING, L.P.	0%	0	-	-9.69K	-100.00%
Dec 31, 2022	ROYAL BANK OF CANADA	0%	0	-	-1.66K	-100.00%
Dec 31, 2022	BRIDGEWAY CAPITAL MANAGEMENT, LLC	0%	0	-	-107.05K	-100.00%
Dec 31, 2022	BAILLIE GIFFORD & CO	0%	0	-	-589.11K	-100.00%
Dec 31, 2022	UBS OCONNOR LLC	0%	0	-	-606.5K	-100.00%
Dec 31, 2022	BLACKROCK INC.	0%	0	-	-563.49K	-100.00%
Dec 31, 2022	MARINER, LLC	0%	0	-	-40.07K	-100.00%
Dec 31, 2022	LAURION CAPITAL MANAGEMENT LP	0%	0	-	-700K	-100.00%
Dec 31, 2022	LPL FINANCIAL LLC	0%	0	-	-104.59K	-100.00%

Insiders

Among the UBX insiders holding of 1.9% of the stake in company, DAVID NATHANIEL E, President, holds the largest shares of 624.7K. GHOSH ANIRVAN, Chief Executive Officer, is the second largest UBX insider with ownership of 153.45K shares. SULLIVAN LYNNE MARIE, CFO & Head of Corp. Dev., stands third with possession of 98.91K shares of that stake.

Insiders	Designation	Shares Held
DAVID NATHANIEL E	President	624.7K
GHOSH ANIRVAN	Chief Executive Officer	153.45K
SULLIVAN LYNNE MARIE	CFO & Head of Corp. Dev.	98.91K
DANANBERG JAMIE	Chief Medical Officer	62.82K
NGUYEN ALEXANDER HIEU	CLO and Head of Ops	48.75K

Buying/Selling by Insiders

Date	Insider	Type	Cost	Shares	Value ($)	Shares Total
Apr 02, 2025	NGUYEN ALEXANDER HIEU	SALE	1.03	17.85K	18.39K	48.75K
Apr 02, 2025	GHOSH ANIRVAN	SALE	1.03	96.8K	99.7K	153.45K
Apr 02, 2025	SULLIVAN LYNNE MARIE	SALE	1.03	21.87K	22.52K	98.91K
Mar 27, 2025	NGUYEN ALEXANDER HIEU	SALE	1.16	1.95K	2.27K	22.61K
Feb 04, 2025	NGUYEN ALEXANDER HIEU	SALE	2.23	164	365.72	24.56K
Feb 04, 2025	GHOSH ANIRVAN	SALE	2.23	642	1.43K	75.25K
Feb 04, 2025	SULLIVAN LYNNE MARIE	SALE	2.23	153	341.19	55.77K
Nov 04, 2024	GHOSH ANIRVAN	SALE	1.29	432	557.28	75.89K
Nov 04, 2024	NGUYEN ALEXANDER HIEU	SALE	1.29	149	192.21	24.72K
Nov 04, 2024	SULLIVAN LYNNE MARIE	SALE	1.29	136	175.44	55.93K
Aug 02, 2024	NGUYEN ALEXANDER HIEU	SALE	1.53	154	235.62	24.87K
Aug 02, 2024	GHOSH ANIRVAN	SALE	1.53	604	924.12	76.33K
Aug 02, 2024	SULLIVAN LYNNE MARIE	SALE	1.53	139	212.67	56.06K
Jun 25, 2024	GHOSH ANIRVAN	SALE	1.40	1.21K	1.7K	76.93K
Jun 25, 2024	NGUYEN ALEXANDER HIEU	SALE	1.40	78	109.2	25.03K
Jun 25, 2024	SULLIVAN LYNNE MARIE	SALE	1.40	324	453.6	32.69K
May 02, 2024	GHOSH ANIRVAN	SALE	1.55	603	934.65	78.14K
Feb 02, 2024	GHOSH ANIRVAN	SALE	1.71	680	1.16K	78.75K
Jan 30, 2024	GHOSH ANIRVAN	SALE	1.71	1.18K	2.02K	79.43K
Nov 02, 2023	GHOSH ANIRVAN	SALE	1.83	589	1.08K	80.61K
Oct 30, 2023	GHOSH ANIRVAN	SALE	1.90	1.02K	1.95K	81.2K
Sep 14, 2023	GHOSH ANIRVAN	SALE	2.47	1.25K	3.08K	82.22K
Aug 02, 2023	GHOSH ANIRVAN	SALE	2.94	581	1.71K	83.47K
Jul 31, 2023	GHOSH ANIRVAN	SALE	2.86	1.02K	2.92K	84.05K
Jun 26, 2023	GHOSH ANIRVAN	SALE	3.20	1.18K	3.77K	85.07K
Jun 14, 2023	GHOSH ANIRVAN	SALE	3.39	1.21K	4.11K	86.25K
May 02, 2023	GHOSH ANIRVAN	SALE	2.17	588	1.28K	87.46K
May 01, 2023	GHOSH ANIRVAN	SALE	2.15	1.02K	2.19K	88
Mar 31, 2023	GHOSH ANIRVAN	SALE	1.70	1.96K	3.33K	89.07K
Mar 31, 2023	DANANBERG JAMIE	SALE	1.70	420	714	62.82K
Mar 14, 2023	GHOSH ANIRVAN	SALE	4.00	1.21K	4.84K	91.03K
Mar 14, 2023	DANANBERG JAMIE	SALE	4.00	1.01K	4.02K	63.24K
Feb 02, 2023	GHOSH ANIRVAN	SALE	4.84	2.57K	12.45K	92.24K
Feb 02, 2023	DANANBERG JAMIE	SALE	4.84	863	4.18K	64.24K
Jan 30, 2023	GHOSH ANIRVAN	SALE	4.45	1.14K	5.07K	94.81K
Dec 14, 2022	DANANBERG JAMIE	SALE	2.85	1.02K	2.9K	65.11K
Dec 14, 2022	GHOSH ANIRVAN	SALE	2.85	1.27K	3.63K	95.95K
Nov 03, 2022	GHOSH ANIRVAN	SALE	2.40	1.1K	2.64K	97.22K
Sep 14, 2022	GHOSH ANIRVAN	SALE	0.48	13.71K	6.58K	983.21K
Sep 14, 2022	DANANBERG JAMIE	SALE	0.48	10.92K	5.24K	661.21K
Aug 01, 2022	GHOSH ANIRVAN	SALE	0.67	10.45K	7K	996.92K
Jun 27, 2022	DANANBERG JAMIE	SALE	0.59	4.4K	2.59K	672.14K
Jun 27, 2022	GHOSH ANIRVAN	SALE	0.59	12.15K	7.17K	1.01M
Jun 21, 2022	DANANBERG JAMIE	SALE	0.62	3.7K	2.29K	676.53K
Dec 16, 2020	DAVID NATHANIEL E	SALE	5.24	1.7M	8.91M	624.7K
Jun 05, 2020	DAVID NATHANIEL E	PURCHASE	8.90	3.2K	28.48K	2.33M

UBX Stock Ownership Breakdown